Access Bio, Inc. · KRX:950130

Access Bio, Inc. financial statements

Access Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue31.3B82.5M267.1M800.2M441.4M103.2M36.9M36.6M26.1M28.0M
Cost of revenue55.7B43.1M136.6M165.7M95.0M26.3M28.9M22.4M18.0M15.9M
Gross profit-24.4B39.3M130.4M634.5M346.4M76.9M8.07M14.2M8.09M12.1M
Research and development8.48B10.8B16.1B7.32B4.89B4.01B
Selling, general and administrative14.1B33.3M100.4M264.7M114.0M14.3M12.1M14.3M11.5M10.8M
Operating income-63.3B-4.12M18.0M363.1M227.1M55.8M-13.9M-4.58M-6.45M-601.2K
Depreciation and amortization17.2B13.4M12.1M8.28M4.83M3.41B3.42B3.07B2.53B1.51M
EBITDA-46.1B9.30M30.2M371.4M232.0M3.47B3.41B3.07B2.53B912.4K
Interest expense2.32B3.47B3.71B6.23B3.35B1.87B0000
Income before tax-105.4B-105.5K-4.50M358.9M224.4M52.9M-18.5M-5.58M-9.33M-49.9K
Income tax14.7B-955.3M243.8M-1.35B
Net income-82.1B-254.8K-2.43M268.3M165.8M40.9M-15.1M-3.85M-5.74M262.1K
Earnings per share, basic-2,334.64-0.01-0.077.904.661.15-0.46-0.15-0.220.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents323.3B232.8M277.6B7.53K3.90K45.2M5.90M4.59M5.46M5.90K
Short-term investments79.7B76.6M69.4B20.1M1.05M1.04M1.02M4.50M933.9K4.17M
Receivables2.44B5.27M17.8B91.2B54.6B27.5B5.90B13.6B10.5B11.5M
Inventory10.7B16.0M32.2B90.1M46.0M28.0B8.10B12.1B12.2B7.27M
Current assets433.3B340.3M418.4B564.8M276.8M111.9B25.9B40.5B35.3B48.6M
Property, plant and equipment93.3M108.2M103.0M68.0M49.1B30.9B30.4B31.4B25.3M
Goodwill0380.0K787.0K821.3K728.1K
Total assets607.9B504.0M691.1B698.7M372.8M156.4M60.2M84.8M87.2M91.2M
Accounts payable612.8M1.15B3.46B2.20B9.74B4.73B1.46B2.68B737.9M
Current liabilities24.9B27.5M44.0B154.9M116.6M69.6B17.7B23.2B17.2B2.41M
Long-term debt014.7B11.7M0140.4K18.6M21.6M17.2M23.9M
Total debt34.9M21.0M23.8M18.1M24.1M
Total liabilities49.5B61.7M104.0B211.0M131.1M79.5M39.0M51.4M46.0M43.7M
Shareholders' equity557.2B442.3M584.2B487.7M241.7M76.9M21.2M33.4M41.1M47.5M
Shares outstanding35.2M35.2M33.8M34.0M35.6M35.6M32.8M26.3M26.3M26.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-29.2B13.5M-80.6M291.3M137.9M36.7B-422.2M-5.73B-5.45B2.11M
Capital spending-1.79B-1.40M-14.4M-14.9M-28.8M-10.4B-3.05B-1.67B-4.20B-10.0M
Free cash flow-31.0B17.9B-122.6B350.3B129.4B26.0B-6.39B-7.40B-9.65B-7.91M
Cash from investing11.9M-36.1M-29.8M-29.5M-8.81B3.19B-4.87B-11.6B-9.74M
Cash from financing-5.14M-41.9M-53.2M15.2M15.3B-707.5M8.65B1.71B23.1M
Dividends paid0-22.8M
Share buybacks0-1.83M-22.1M12.7K259.6K8.57M-2.16M-1.05M
Change in cash-10.7B17.5M-158.1M205.5M122.7M42.8B1.50B-2.09B-15.4B14.9M